About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Phoenix | 242 Studies

Clinical Trials Alzheimer's DiseasePhoenix

Alzheimer's Disease Clinical Trials in Phoenix

Find 242 clinical trials for alzheimer's disease near Phoenix, Arizona. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 201-220 of 242 trials

CompletedStudy of BHV-4157 in Alzheimer's DiseasePreclinical models suggest that riluzole, the active metabolite of BHV-4157, may protect from AD-related pathology and cognitive dysfunction.NCT03605667·Phoenix, Arizona and 43 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedA Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205The primary objective is to evaluate the safety and tolerability of aducanumab over 100 weeks of treatment after a wash-out period imposed by discontinuation of feeder studies in…NCT04241068·Birmingham, Alabama and 296 others

CompletedA Study of Mevidalen (LY3154207) in Participants With Alzheimer's DiseaseThe main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people with mild to moderate Alzheimer…NCT06538116·Phoenix, Arizona and 63 others

CompletedA Study of Gantenerumab in Participants With Prodromal Alzheimer's DiseaseThis multi-center, randomized, double-blind, placebo-controlled parallel-group study will evaluate the effect of gantenerumab (RO4909832) on cognition and functioning and the…NCT01224106·Phoenix, Arizona and 138 others

RecruitingEarly-Stage Partner in Care Living Alone PlusEPICLA+ (Early-Stage Partners in Care Living Alone Plus) is a research project designed to assist people with early-stage memory loss who live alone in the community by providing…NCT06962111·Phoenix, Arizona

TerminatedStudy of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025This is a 26-week, randomized extension of the Phase 3 double-blind placebo-controlled studies, EVP-6124-024 and EVP-6124-025.NCT02004392·Phoenix, Arizona and 85 others

CompletedELND005 Long-Term Follow-up Study in Subjects With Alzheimer's DiseaseThe purpose of this study is to evaluate the long-term safety and tolerability of ELND005 beyond the 18 months of treatment in original randomized and blinded clinical trail…NCT00934050·Phoenix, Arizona and 37 others

TerminatedA Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease DementiaThis study is an extension of study I8D-MC-AZES (NCT02245737), the AMARANTH study.NCT02972658·Phoenix, Arizona and 132 others

CompletedA Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)The purpose of this study is to evaluate the safety, tolerability and efficacy of LY3002813 in early symptomatic Alzheimer's disease.NCT03367403·Phoenix, Arizona and 60 others

CompletedEfficacy and Safety of Aricept in the Treatment of Severe Alzheimer's DiseaseDonepezil hydrochloride (Aricept) has been approved to treat symptoms associated with mild to moderate Alzheimer's disease (AD).NCT00096473·Northport, Alabama and 41 others

CompletedA Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®A Phase 1, Randomized, Open-Label, 3-Way Crossover, Pilot, Pharmacokinetic Study to Evaluate the Steady State Pharmacokinetics of a Once-Weekly Application of Corplex Donepezil…NCT02968719·Phoenix, Arizona

CompletedEffect of LY2062430 on the Progression of Alzheimer's DiseaseAlzheimer's disease (AD) is an age-related degenerative disorder of the brain, characterized by progressive decline in cognitive function and ability to perform activities of…NCT00905372·Phoenix, Arizona and 84 others

TerminatedOpen-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 ProtocolOpen-label treatment with MPC-7869 for participants in a previous randomized study.NCT00380276·Alabaster, Alabama and 89 others

Active not recruitingA Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.NCT04437511·Gilbert, Arizona and 273 others

CompletedSafety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's DiseaseThe purpose of this study is to determine the safety and efficacy of TRx0237 in the treatment of subjects with mild Alzheimer's Disease.NCT01689233·Phoenix, Arizona and 94 others

CompletedEfficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to determine the efficacy of ramelteon, once daily (QD), in subjects with mild to moderate Alzheimer's Disease and sleep disturbanceNCT00325728·Alabaster, Alabama and 71 others

TerminatedAn Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD)The purpose of this study is to assess the long-term safety and tolerability of ABBV-8E12 in participants with early AD.NCT03712787·Phoenix, Arizona and 56 others

CompletedThe Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's DiseaseMemory loss and difficulties with thinking associated with Alzheimer's disease may be due to chronic release of a brain chemical called glutamate.NCT00090116·Peoria, Arizona and 33 others

CompletedA Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)This is a randomized, double-blind, sham-controlled pivotal study of sensory stimulation in subjects with mild to moderate AD.NCT05637801·Gilbert, Arizona and 67 others

TerminatedA Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's DiseaseA long-term extension study to evaluate the safety, tolerability, and efficacy of AL002 in participants with Early Alzheimer's Disease.NCT05744401·Phoenix, Arizona and 53 others

PreviousPage 11 of 13Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia